AbbVie and Johnson & Johnson are top exposures in the VYM ETF, which itself holds Microsoft.

The entities involved

• AbbVie →

  pharmaceutical company

  • MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
  • AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
• Johnson & Johnson →

  U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer

  • P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
  • Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
• Microsoft →

  American multinational technology corporation

  • Nvidia is expanding its platform deployment across major cloud providers, including Google Cloud and Microsoft Azure.Mon 17:31
  • Cloud giants, including Microsoft, Amazon, Anthropic, OpenAI, and Google, are benefiting from overall AI market growth while navigating corporate cost containment and future market competition.Mon 16:50

Related events

• Johnson & Johnson highlighted growth opportunities within the MedTech sector.Sep 10
• Medical device sales are up in the U.S., but major players like J&J are facing market headwinds due to the VBP program in China.Jun 7
• Johnson & Johnson and Mastercard are currently top holdings within the JEPI investment fund.Sep 8
• Johnson & Johnson, JPMorgan Chase, and AbbVie are dividend payers in the VYM fund.Thu 23:50